Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran

Skin and Subcutaneous Tissue Fungal Infections Clinical Trial

Official title:

The Comparison of Dermatophytosis and Other Fungal Infections Between Drug Users and Non Drug Users

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02681458
• Other study ID #: IslamicAUM
• Status: Completed
• Phase: N/A
• First received: January 31, 2016
• Last updated: February 11, 2016
• Start date: August 2013
• Est. completion date: April 2014

Study information

• Verified date: February 2016
• Source: Islamic Azad University of Mashhad
• Contact: n/a
• Is FDA regulated: No
• Health authority: Iran: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The purpose of this study was about survey of prevalence of fungal infections among drug users referring to methadone wards of Hospitals in northeast region of Iran

Description:

There were two groups with overall members of 1436. Statistically, the investigators have used "Likelihood ratio " and " Exact's Fisher" tests.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1436
• Est. completion date: April 2014
• Est. primary completion date: March 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Suspected fungal lesions

Exclusion Criteria:

• non use of local or edible anti-fungal drugs and not taking bath within the last 48 hours of testing

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Infection
• Mycoses
• Skin and Subcutaneous Tissue Fungal Infections

Intervention

Other:
• Direct Examination
It was an observational study and subjects received their routine treatment.

Locations

Country	Name	City	State
Iran, Islamic Republic of	Islamic Azad University of Mashhad	Mashhad	Khorasan razavi

Sponsors (1)

Lead Sponsor	Collaborator
Islamic Azad University of Mashhad

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The prevalence of superficial and cutaneous fungal infections among drug users		up to two months	Yes